Actively Recruiting

Age: 18Years +
All Genders
NCT06634381

Patient Descriptors Of Cancer-Related Fatigue: A Mixed Methods Pilot Study Of Cancer Survivors

Led by Wake Forest University Health Sciences · Updated on 2026-02-02

80

Participants Needed

3

Research Sites

168 weeks

Total Duration

On this page

Sponsors

W

Wake Forest University Health Sciences

Lead Sponsor

A

Atrium Health Levine Cancer Institute

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this research study is to better understand how cancer-related fatigue affects patients and how it's discussed with providers. This information will be used to develop an educational resource (visual aid poster) that could help individuals and their providers talk about cancer-related fatigue and which may help individuals better manage this symptom.

CONDITIONS

Official Title

Patient Descriptors Of Cancer-Related Fatigue: A Mixed Methods Pilot Study Of Cancer Survivors

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Ability to comply with study procedures for the duration of the study
  • Written informed consent and HIPAA authorization for release of personal information
  • Ability to read, write, understand, and converse in English without an interpreter
  • Men and women aged 18 years or older at the time of consent
  • White or Caucasian, Black or African American, or Hispanic or Latino/a
  • History of at least one visit for long-term care monitoring post curative treatment at LCH and/or Charlotte or Winston-Salem campuses of AHWFBCCC
  • Completed curative cancer treatment more than 6 months ago with no detectable cancer
  • Self-reported fatigue score of 4 or higher on the Numerical Rating Scale
  • Clinicians currently seeing oncology patients for survivorship care at LCH and/or Charlotte or Winston-Salem campuses of AHWFBCCC
Not Eligible

You will not qualify if you...

  • Continuing maintenance therapy or other cancer-related treatments such as immunotherapy or hormonal therapy
  • History of or current severe or untreated depression
  • Hemoglobin less than 11 g/dL at last CBC SOC lab test
  • History or diagnosis of dementia
  • Conditions that may interfere with study participation or assessment results, including medical comorbidities or brain tumors/metastases
  • No access to internet or Wi-Fi
  • No exclusion criteria listed for clinicians

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Levine Childrens Hospital Pediatric Cancer and Blood Disorders

Charlotte, North Carolina, United States, 28203

Actively Recruiting

2

Levine Cancer Institute

Charlotte, North Carolina, United States, 28204

Actively Recruiting

3

Wake Forest Baptist Comprehensive Cancer Center

Winston-Salem, North Carolina, United States, 27157

Actively Recruiting

Loading map...

Research Team

M

Megan Lattanze

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here